SARS News and Research

RSS

Effectiveness of COVID-19 vaccines in New York State

A new study reports that BNT162b2 booster doses are safe and have shown enhancement in short-term protection against the Delta variant.

3 Dec 2021

Quantum mechanical model offers insights into SARS-CoV-2 evolution

Researchers used an ab initio full quantum mechanical model to characterize the spike protein RBD interactions with host cells and gain mechanistic insights into SARS-CoV-2 evolution.

3 Dec 2021

Predicting COVID-19 transmission dynamics in the USA

Researchers used an SEIR type compartmental model to predict the dynamics of COVID-19 transmission in the USA.

3 Dec 2021

Subcutaneously administered monoclonal antibodies associated with reduced hospitalization and death amongst COVID 19 outpatients

A new preprint describes the results of a study that compares intravenous administration of one such therapy to its subcutaneous use, in terms of clinical outcomes.

3 Dec 2021

Characterization of two novel SARS-CoV-2 delta variant sublineages

Researchers characterized the two novel AY.43 sublineages of the SARS-CoV-2 delta variant with probable Brazilian origin.

3 Dec 2021

CRISPR-based DETECTR® assay for faster SARS-CoV-2 surveillance

Researchers from the USA discuss the development and validation of CRISPR-Cas12-based COVID-19 variant DETECTR® assay for the detection of SARS-CoV-2.

3 Dec 2021

Risk of COVID-19 hospitalization among children with markers of uncontrolled asthma

The paper describes a national cohort study including all children in Scotland between the ages of 5 and 17 years who were part of the Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II).

3 Dec 2021

Novel peptide-antibody fusion molecule enhances SARS-CoV-2 variant neutralization

A recent study reports neutralizing efficacy for a fused peptide-antibody molecule against SARS-CoV-2, providing hope that therapeutic neutralizing antibodies may soon be available.

3 Dec 2021

Study finds third dose of BNT162b2 or mRNA-1273 is moderately effective against post-vaccination COVID-19 infection

The current study used VHA electronic health records (EHR) to estimate the effectiveness of the booster dose in the USA against post-vaccination COVID-19.

3 Dec 2021

Pediatric COVID-19 and PIMS-TS: hospitalization, severe disease and mortality risk

The aim of the study was to assess the risk for these outcomes among children of various ages.

3 Dec 2021

Modeling emergence and dynamics of new COVID-19 variants in the UK

Computer simulations describe global features observed in the daily number of cases and can be applied to any country of interest.

3 Dec 2021

Automate your sample pooling with INTEGRA’s efficient pipetting solutions

INTEGRA’s automated pipetting solutions are helping scientists meet the challenge of efficiently pooling potentially infectious samples prior to testing.

From INTEGRA Biosciences 3 Dec 2021

Hybrid immunity provides the highest and most durable immunity against SARS-CoV-2 infection

...

2 Dec 2021

In-depth analysis of SARS-CoV-2 specific T cells in unexposed individuals

A new study aimed to analyze SARS-CoV-2 specific T-cells in unexposed individuals.

2 Dec 2021

Link between tobacco product use and alcohol consumption with anti-SARS-CoV-2 antibody titers after BNT162b2 vaccine

In a Japanese study, smoking, HNB tobacco products, and alcohol use have been shown to impair the immunological response to the COVID-19 vaccination.

2 Dec 2021

Special collection of articles highlights China's response to covid-19

Today, The BMJ is launching a special collection of articles on China's response to covid-19 - what it was, how it worked, why traditional public health measures played such a vital role, and how other countries can learn from this experience to protect their populations, in particular in future pandemics.

2 Dec 2021

New interactive graphic tool illustrates SARS-CoV-2 transmission routes and mitigations

A new interactive graphic developed by UK researchers and published by The BMJ today will help people decide what to do in everyday situations to protect themselves, and others, from covid-19.

2 Dec 2021

SARS-CoV-2 evolution in animals could provide insights on the mutability of COVID-19

When animals catch COVID-19 from humans, new SARS-CoV-2 variants can arise. To evaluate this phenomenon, an interdisciplinary team at the College of Veterinary Medicine and Biomedical Sciences systematically analyzed mutation types occurring in the virus after infection of cats, dogs, ferrets, and hamsters.

2 Dec 2021

Mini-stomach organoids could be used to study how SARS-CoV-2 infection affects children

The team, led from Great Ormond Street Hospital (GOSH), UCL Great Ormond Street Institute of Child Health (UCL GOS ICH) and the Istituto Zooprofilattico Sperimentale delle Venezie (Legnaro, Italy), have built on recent advances to grow 'mini-organs' in a laboratory, known as organoids.

2 Dec 2021

Green seaweed extract exhibits anti-SARS-CoV-2 activity in vitro

Researchers investigate the antiviral activities of SSPS extracted from green seaweed Ulva sp. to demonstrate the anti-SARS-CoV-2 activity of ulvans.

2 Dec 2021

SARS News and Research

Effectiveness of COVID-19 vaccines in New York State

Quantum mechanical model offers insights into SARS-CoV-2 evolution

Predicting COVID-19 transmission dynamics in the USA

Subcutaneously administered monoclonal antibodies associated with reduced hospitalization and death amongst COVID 19 outpatients

Characterization of two novel SARS-CoV-2 delta variant sublineages

CRISPR-based DETECTR® assay for faster SARS-CoV-2 surveillance

Risk of COVID-19 hospitalization among children with markers of uncontrolled asthma

Novel peptide-antibody fusion molecule enhances SARS-CoV-2 variant neutralization

Study finds third dose of BNT162b2 or mRNA-1273 is moderately effective against post-vaccination COVID-19 infection

Pediatric COVID-19 and PIMS-TS: hospitalization, severe disease and mortality risk

Modeling emergence and dynamics of new COVID-19 variants in the UK

Automate your sample pooling with INTEGRA’s efficient pipetting solutions

Hybrid immunity provides the highest and most durable immunity against SARS-CoV-2 infection

In-depth analysis of SARS-CoV-2 specific T cells in unexposed individuals

Link between tobacco product use and alcohol consumption with anti-SARS-CoV-2 antibody titers after BNT162b2 vaccine

Special collection of articles highlights China's response to covid-19

New interactive graphic tool illustrates SARS-CoV-2 transmission routes and mitigations

SARS-CoV-2 evolution in animals could provide insights on the mutability of COVID-19

Mini-stomach organoids could be used to study how SARS-CoV-2 infection affects children

Green seaweed extract exhibits anti-SARS-CoV-2 activity in vitro

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News